'Gene Patents in Europe Relatively Stable Despite Uncertainty in the US', by Andrew Sharples

Partner and head of EIP Life, Andrew Sharples, has had an article published on the website of a US biotech magazine, Genetic Engineering and Biotechnology News (GEN).

The article entitled Gene Patents in Europe Relatively Stable Despite Uncertainty in the US, discusses the future of gene patents in Europe contrasting the European position with the US Myriad case.

To read the article in full, click here.